KIR haplotypes are associated with late-onset type 1 diabetes in European–American families

被引:0
|
作者
J A Traherne
W Jiang
A M Valdes
J A Hollenbach
J Jayaraman
J A Lane
C Johnson
J Trowsdale
J A Noble
机构
[1] University of Cambridge,Division of Immunology, Department of Pathology
[2] Cambridge Institute for Medical Research,Department of Neurology
[3] University of Cambridge,undefined
[4] Academic Rheumatology,undefined
[5] University of Nottingham,undefined
[6] City Hospital,undefined
[7] University of California San Francisco School of Medicine,undefined
[8] Children’s Hospital Oakland Research Institute,undefined
来源
Genes & Immunity | 2016年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Classical human leukocyte antigens (HLA) genes confer the strongest, but not the only, genetic susceptibility to type 1 diabetes. Killer cell immunoglobulin-like receptors (KIR), on natural killer (NK) cells, bind ligands including class I HLA. We examined presence or absence, with copy number, of KIR loci in 1698 individuals, from 339 multiplex type 1 diabetes families, from the Human Biological Data Interchange, previously genotyped for HLA. Combining family data with KIR copy number information allowed assignment of haplotypes using identity by descent. This is the first disease study to use KIR copy number typing and unambiguously define haplotypes by gene transmission. KIR A1 haplotypes were positively associated with T1D in the subset of patients without the high T1D risk HLA genotype, DR3/DR4 (odds ratio=1.29, P=0.0096). The data point to a role for KIR in type 1 diabetes risk in late-onset patients. In the top quartile (age of onset>14), KIR A2 haplotype was overtransmitted (63.4%, odds ratio=1.73, P=0.024) and KIR B haplotypes were undertransmitted (41.1%, odds ratio=0.70, P=0.0052) to patients. The data suggest that inhibitory ‘A’ haplotypes are predisposing and stimulatory ‘B’ haplotypes confer protection in both DR3/DR4-negative and late-onset patient groups.
引用
收藏
页码:8 / 12
页数:4
相关论文
共 50 条
  • [1] KIR haplotypes are associated with late-onset type 1 diabetes in European-American families
    Traherne, J. A.
    Jiang, W.
    Valdes, A. M.
    Hollenbach, J. A.
    Jayaraman, J.
    Lanes, J. A.
    Johnson, C.
    Trowsdale, J.
    Nobles, J. A.
    GENES AND IMMUNITY, 2016, 17 (01) : 8 - 12
  • [2] STAT4 Polymorphism Is Associated with Early-Onset Type 1 Diabetes, but Not with Late-Onset Type 1 Diabetes
    Lee, Hye-Soon
    Park, Hyewon
    Yang, Seiwon
    Kim, Dukhee
    Park, Yongsoo
    IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE, 2008, 1150 : 93 - 98
  • [3] Late-onset autoimmune diabetes in relatives of people with type 1 diabetes
    Fourlanos, S
    Colman, PG
    Harrison, LC
    IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 : 370 - 373
  • [4] Late-onset type 1 diabetes in Pasifika migrants living in Auckland
    Purea, T.
    McCready, F.
    Dunn, P.
    Cundy, T.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (01) : 104 - 105
  • [5] HLA haplotypes in families with type 1 diabetes
    Pérez, F
    Santos, JL
    Calvillán, M
    Carrasco, E
    REVISTA MEDICA DE CHILE, 1998, 126 (12) : 1455 - 1463
  • [6] Late-Onset Type 1 Diabetes Mellitus and Unexplained Subcutaneous Lesions
    Tunc, Malik A.
    Amireh, Karim
    Brar, Kevin
    Bondalapati, Ramyaprabha
    Novo, Pedro
    Podcheko, Alexey
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [7] A MODEL OF LATE-ONSET DIABETES
    RENIE, WA
    MURPHY, EA
    PYERITZ, RE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1983, 35 (06) : A113 - A113
  • [8] LATE-ONSET DIABETES 1989
    BURGI, U
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 120 (22) : 809 - 816
  • [9] LATE-ONSET DIABETES IN ISRAEL
    COHEN, AM
    FIDEL, J
    COHEN, B
    YODFAT, Y
    EISENBERG, S
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (12): : 1003 - 1008
  • [10] Cullin 1 is not associated with late-onset preeclampsia
    Samara, Tjam Diana
    Liem, Isabella Kurnia
    Prijanti, Ani Retno
    Andrijono
    UNIVERSA MEDICINA, 2019, 38 (01) : 4 - 9